Dr. Adam Christopher Stage, MD

Dr. Stage practices at Ochsner LSU Health - St. Mary Medical Center in Shreveport, Louisiana, part of Ochsner Health System.

Dr. Stage's NPI, 1780651489, was assigned on March 2, 2006. Dr. Stage graduated from LSU School of Medicine in Shreveport in 2001. Dr. Stage holds Louisiana license 200689.

Dr. Stage's primary practice is Ochsner LSU Health - St. Mary Medical Center, at 1 St Mary Place, Shreveport, LA 71101 in Caddo Parish. The practice phone is (318) 626-4300.

Dr. Stage's primary practice is Ochsner LSU Health - St. Mary Medical Center in Shreveport, Louisiana, part of Ochsner Health System. Dr. Stage is also affiliated with Willis Knighton North. The medical group on file is LSU Health Shreveport. Dmand AI also links Dr. Stage to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stage practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Stage's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Stage is licensed in Louisiana.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, testicular dysfunction and urinary endoscopy among the conditions Dr. Stage treats.

CMS data shows 81,991 Medicare services from Dr. Stage across 20 procedure codes in 2024, for 342 Medicare patients. Medicare paid $199,574 for them.

CMS counts 342 Medicare patients who saw Dr. Stage in 2024. The largest group is 65 to 74, with 164 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stage's median patient age at 70, with 21% women.

In 2024, Dr. Stage wrote 1,157 Medicare Part D claims for 269 patients. 80% of them were for generic drugs. CMS names the drug for 1,050 of them, across 16 drugs with 11 or more claims each, at $106,843 in total drug cost. In 2023, CMS named 605 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Stage for performance year 2024, reported through an alternative payment model (APM). Dr. Stage accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Stage. Dr. Stage's most frequent co-authors are John C. Hairston, MD and Surena F. Matin, FACS, MD.

CMS Open Payments shows 302 general payments to Dr. Stage from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Axonics, Inc. paid the most, $1,262.

Dr. Stage graduated from LSU School of Medicine in Shreveport in 2001.

Dr. Stage is in network with 22 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.